ID   TMBL-1
AC   CVCL_A1UB
DR   cancercelllines; CVCL_A1UB
DR   IARC_TP53; 18838
DR   Wikidata; Q105511231
RX   PubMed=12802925;
CC   Population: Japanese.
CC   Doubling time: 96 hours (PubMed=12802925).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=12802925).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4673; Acute biphenotypic leukemia
DI   ORDO; Orphanet_530995; Mixed phenotype acute leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=12802925; DOI=10.1080/1042819031000068061;
RA   Suzuki S., Uozumi K., Hanada S., Lin X.-Y., Ohno N., Takatsuka Y.,
RA   Takeuchi S., Owatari S., Takeshita T., Arima T.;
RT   "A novel c-kit positive biphenotypic acute leukemia cell line, TMBL-1,
RT   carrying a p53 point mutation.";
RL   Leuk. Lymphoma 44:849-857(2003).
//